Factbox-Anthropic’s public benefit fund and how it compares with other big philanthropic efforts

Guggenheim raises Rapport Therapeutics price target to $70 on trial data

Investing.com · News 19m ago

US yields ease off lows as stocks rally

LiveMint · Markets 20m ago

Amazon to hire over 300,000 seasonal workers for holidays

Investing.com · News 25m ago

Silence Therapeutics stock hits 52-week high at 19.62 USD

Investing.com · News 27m ago

Canadian Stock Market Rallies As Tech Leads Recovery

NASDAQ · Markets 28m ago

Crude Oil Slumps Amid Reports Of Possible U.S.-Iran Deal

NASDAQ · Commodities 29m ago

General Mills Stock Is Down 30%, and Wall Street Analysts Keep Cutting Their Price Targets. Here's Why History Says They're Missing the Bigger Picture.

NASDAQ · Markets 31m ago

ACCESS Newswire at LD Micro event: growth plan shifts to recurring revenue

Investing.com · News 31m ago

MannKind at Chardan’s 10th Annual Healthcare Conference: pipeline broadens

Investing.com · News 32m ago

Vicore at Chardan’s 10th annual healthcare conference: IPF bet builds

Investing.com · News 33m ago